A sustained WTI price above $55 could catalyze an OXY recovery narrative into 2027, but near-term upside remains limited. A ...

Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

A new KFF analysis reveals that retrospective chart reviews are a primary driver of risk-adjusted payments for Medicare Advantage insurers, often adding diagnoses, and revenue, without accompanying ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

Chemicals business underperforms due to global oversupply Retail and digital services show steady revenue growth Jio Platforms profit rises 12.8% BENGALURU/NEW DELHI, Oct 17 (Reuters) - Indian ...

A spate of recent deals among AI's biggest players has tightened the circle of companies and investments underpinning the technology’s explosive growth. Nvidia plans to invest in OpenAI, which is ...

Most telecom companies still treat order-to-cash (O2C) like a back-office assembly line, resulting in fragile launches, billing mistakes and customer churn that could have been avoided. What if we ...